Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06704828
What this trial is testing

A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Study completedNCT02583165
What this trial is testing

A Study in Adult Subjects With Select Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 40
Early research (Phase 1)Active Not RecruitingNCT03889795
What this trial is testing

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

Who this might be right for
Advanced Pancreatic CancerAdvanced Solid Tumor
Danae Hamouda, MD 15
Early research (Phase 1)Study completedNCT06231277
What this trial is testing

Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumours
Zhuhai Beihai Biotech Co., Ltd 12
Early research (Phase 1)Looking for participantsNCT06010875
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Renal Cell CarcinomaOvarian CancerCervix Cancer+2 more
Chongqing Precision Biotech Co., Ltd 48
Not applicableUnknownNCT05952375
What this trial is testing

Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial

Who this might be right for
Gastric Cancer
The Affiliated Hospital of Qingdao University 9
Early research (Phase 1)Study completedNCT03027128
What this trial is testing

QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
ImmunityBio, Inc. 6
Early research (Phase 1)Study completedNCT01458067
What this trial is testing

A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency

Who this might be right for
Cancer
GlaxoSmithKline 30
Early research (Phase 1)Looking for participantsNCT05948865
What this trial is testing

CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
CancerCancer, Lung
Conjupro Biotherapeutics, Inc. 132
Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Early research (Phase 1)Study completedNCT00116896
What this trial is testing

Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
OSI Pharmaceuticals 25
Early research (Phase 1)Study completedNCT01494688
What this trial is testing

RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hoffmann-La Roche 217
Early research (Phase 1)Active Not RecruitingNCT05598151
What this trial is testing

Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hanmi Pharmaceutical Company Limited 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT05438329
What this trial is testing

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
DualityBio Inc. 1,123
Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Early research (Phase 1)Study completedNCT01673737
What this trial is testing

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Who this might be right for
Neoplasm Malignant
Sanofi 75
Early research (Phase 1)Study completedNCT04252339
What this trial is testing

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Unspecified, Adult
Hoffmann-La Roche 56
Early research (Phase 1)Study completedNCT04840394
What this trial is testing

Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Tumor, Solid
Eikon Therapeutics 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04266912
What this trial is testing

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
M.D. Anderson Cancer Center 23
Early research (Phase 1)Active Not RecruitingNCT05163028
What this trial is testing

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Who this might be right for
Non Small Cell Lung CancerColorectal CancerPancreatic Cancer+4 more
HUYABIO International, LLC. 42
Next Page